clopidogrel has been researched along with Graft Occlusion, Vascular in 135 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.96) | 18.2507 |
| 2000's | 55 (40.74) | 29.6817 |
| 2010's | 69 (51.11) | 24.3611 |
| 2020's | 7 (5.19) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Han, Z; Zhang, G | 1 |
| Ahn, CM; Cho, S; Choi, D; Choi, SH; Gwon, HC; Hahn, JY; Hong, MK; Hong, SJ; Jang, Y; Kang, TS; Kim, BK; Kim, JS; Ko, YG; Shin, DH; Song, YB | 1 |
| Ben-Yehuda, O; Claessen, BE; Crowley, A; Faggioni, M; Farhan, S; Généreux, P; Kirtane, AJ; Maehara, A; Mastoris, I; Mehran, R; Redfors, B; Stone, GW; Weisz, G; Witzenbichler, B | 1 |
| Dickson, SD; Govea, A; Penny, W; Taleb, A; Wiernek, S | 1 |
| Baldetti, L; Beneduce, A; Calvo, F; Capodanno, D; Cappelletti, AM; D'Ascenzo, F; De Ferrari, GM; Gallone, G; Godino, C; Gramegna, M; Melillo, F; Moroni, F; Pagnesi, M; Venuti, A | 1 |
| Haruta, H; Hirayama, A; Hiro, T; Kitano, D; Kurosawa, T; Li, Y; Matsumoto, T; Migita, S; Mitsumata, M; Okumura, Y; Sudo, M; Takahashi, R; Takayama, T; Taniguchi, Y | 1 |
| Chen, PR; Gupta, V; Inam, ME; Kermali, K; Lekka, E; Lopez-Rivera, V; Maud, A; Pedroza, C; Rodriguez, G; Sheriff, F; Sheth, S; Thanh Truong, VT | 1 |
| Dixon, SR; Gurm, HS; Khandelwal, A; LaLonde, TA; Seth, M; Sukul, D | 1 |
| Cai, M; Chen, S; Fang, Z; Lan, B; Li, R; Ma, C; Yang, Y; Zhu, T | 1 |
| Ayele, GM; Ben-Yehuda, O; Cox, DA; Duffy, PL; Furer, A; Généreux, P; Giustino, G; Henry, TD; Kirtane, AJ; Lin, SH; Maehara, A; Mazzaferri, EL; Mehran, R; Metzger, DC; Mintz, GS; Neumann, FJ; Redfors, B; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B | 1 |
| Godschalk, TC; Kelder, JC; Ten Berg, JM; Zwart, B | 1 |
| Chai, HT; Chang, HW; Chen, CJ; Chen, KH; Chua, S; Chung, SY; Lee, WC; Liu, CF; Sung, PH; Tong, MS; Yip, HK | 1 |
| de Belder, MA; Freeman, P; Johnson, T; Kontopantelis, E; Kwok, CS; Ludman, P; Mamas, MA; Sirker, A; Zaman, A | 1 |
| Akasaka, T; Hariki, H; Hiranuma, N; Hirata, KI; Inoue, T; Iwasaki, M; Kinutani, H; Konishi, A; Kuroda, M; Nakagawa, M; Nakamura, M; Nishio, R; Osue, T; Otake, H; Saito, S; Shinke, T; Shite, J; Taniguchi, Y | 1 |
| Chaparro, E; Fedorova, E; Griffin, A; Hauck, EF; Holmes, C; Manson, RJ | 1 |
| Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW | 1 |
| Brodie, BR; Généreux, P; Gohs, FX; Kirtane, AJ; Maehara, A; McAndrew, T; Mehran, R; Metzger, DC; Neumann, FJ; Redfors, B; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B | 1 |
| Batista, DV; Feitosa, MPM; Lima, EG; Linhares Filho, JPP; Lobo Filho, HG; Serrano Júnior, CV; Soffiatti, CD | 1 |
| Altarabsheh, SE; Boilson, BA; Deo, SV; Dunlay, SM; Erwin, PJ; Joyce, LD; Park, SJ; Shah, IK | 1 |
| Jerzewski, K; Kulik, A; Le May, MR; Ruel, M; Voisine, P | 1 |
| Calcagno, S; Lucisano, L; Mancone, M; Pennacchi, M; Sardella, G; Stio, RE | 1 |
| Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P | 1 |
| Almassi, GH; Ardehali, A; Bakaeen, FG; Baltz, JH; Collins, JF; Ebrahimi, R; Grover, FL; Hattler, B; Shroyer, AL; Uberoi, A; Wagner, TH | 1 |
| Belardi, JA; Brar, S; Kirtane, AJ; Liu, M; Rothman, M; Silber, S; Windecker, S | 1 |
| Al Kurdi, M; Boersma, E; Camenzind, E; Mauri, L; Ordoubadi, FF; Rademaker-Havinga, T; Steg, PG; Suttorp, MJ; Wijns, W | 1 |
| Bach, RG; Becker, RC; Budaj, A; Heras, M; Himmelmann, A; Horrow, J; Husted, S; James, SK; Katus, HA; Lassila, R; Morais, J; Nicolau, JC; Steg, PG; Storey, RF; Wallentin, L; Wojdyla, D | 1 |
| Chen, F; Loh, JP; Omar, A; Pendyala, LK; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
| Guo, B; Guo, D; Guo, W; Shi, Z; Tan, Q; Zhang, C | 1 |
| Antonopoulos, C; Kakisis, JD; Liapis, CD; Moulakakis, K; Sfyroeras, G; Vassilas, K | 1 |
| Agrawal, N; Parekh, P; Vasavada, A; Vinchurkar, M | 1 |
| Chen, Y; Dong, W; Fu, Z; Guo, J; Han, Y; Jing, J; Shen, M; Xue, H; Yang, X | 1 |
| Alexander, JH; Califf, RM; Englum, BR; Gibson, CM; Hager, R; Hess, CN; Kouchoukos, NT; Lopes, RD; Mack, MJ; Peterson, ED; Wojdyla, DM | 1 |
| Bliden, KP; Gesheff, M; Gurbel, PA; Liu, F; Tantry, US | 1 |
| Agostoni, P; Stella, PR; Timmers, L | 1 |
| Christ, G; Dechant, C; Francesconi, M; Grohs, K; Podczeck-Schweighofer, A; Siller-Matula, JM | 1 |
| Bolanos, MD; Ferraris, VA | 1 |
| Abdel-Wahab, M; Adriaenssens, T; Angiolillo, DJ; Bernlochner, I; Byrne, RA; Desmet, W; Feuchtenberger, A; Fischer, M; Han, Y; Hengstenberg, C; Ibrahim, T; Jacobshagen, C; Janssen, PW; Kastrati, A; Kufner, S; Laugwitz, KL; Li, Y; Maeng, M; Mehilli, J; Morath, T; Mudra, H; Neumann, FJ; Rifatov, N; Schömig, A; Schulz-Schüpke, S; Schunkert, H; Seyfarth, M; Ten Berg, JM; Tiroch, K; Tölg, R; Valina, C; von Hodenberg, E; von Merzljak, B; Wöhrle, J; Zrenner, B | 1 |
| Jim, MH; Wong, KL; Yiu, KH | 1 |
| Angiolillo, DJ; Aradi, D; Bonello, L; Cuisset, T; Freynhofer, MK; Gurbel, PA; Huber, K; Janssen, P; Kastrati, A; Kirtane, A; Mangiacapra, F; Marcucci, R; Morel, O; Palmerini, T; Patti, G; Price, MJ; Sibbing, D; Siller-Matula, JM; Stone, GW; Tantry, US; ten Berg, J; Valgimigli, M | 1 |
| Chen, D; Jiang, Q; Liu, C; Liu, H; Liu, M; Lu, J; Zuo, L | 1 |
| Abbate, R; Antoniucci, D; Cantini, G; Carrabba, N; Cerisano, G; Comito, V; Gensini, GF; Gori, AM; Marcucci, R; Marrani, M; Migliorini, A; Parodi, G; Valenti, R; Vergara, R | 1 |
| Bhatt, DL; Blankenship, JC; Deliargyris, EN; Généreux, P; Gibson, CM; Gutierrez, JA; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
| Ariotti, S; Biscaglia, S; Campo, G; Costa, F; Esposito, G; Gargiulo, G; Leonardi, S; Valgimigli, M; Vranckx, P; Windecker, S | 1 |
| Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD | 1 |
| Álvarez Cubero, MJ; Cabeza Barrera, J; Carmona-Sáez, P; Dávila-Fajardo, CL; Díaz-Villamarín, X; Fernández-Quesada, F; Martínez-González, LJ; Salmerón-Febres, LM; Sánchez-Ramos, J | 1 |
| Barbieri, L; Brouwer, MA; Camaro, C; Damen, SA; de Boer, MJ; De Luca, G; Kedhi, E; Lee, SW; Ligtenberg, E; Rognoni, A; Suryapranata, H; van T Hof, AW; Verdoia, M | 1 |
| Chen, SL; Gao, XF; Ge, Z; Lin, S; Liu, ZZ; Tian, NL; Ye, F; Zhang, JJ | 1 |
| Bekta, P; Chmielak, Z; Debski, A; Jamiolkowski, J; Klopotowski, M; Kukula, K; Kunicki, PK; Polanska-Skrzypczyk, M; Witkowski, A | 1 |
| Abizaid, A; Angelini, GD; Bacchi Reggiani, L; Benedetto, U; Bhatt, DL; Biondi-Zoccai, G; Chieffo, A; Colombo, A; Della Riva, D; Feres, F; Généreux, P; Gilard, M; Hong, MK; Jang, Y; Kim, BK; Kim, HS; Morice, MC; Palmerini, T; Park, KW; Pufulete, M; Sangiorgi, D; Stone, GW; Valgimigli, M; White, J | 1 |
| Alper, AT; Ates, M; Demirtas, MM; Gunay, R; Idiz, M; Kayacioglu, I; Saskin, H; Sensoz, Y; Tangurek, B; Yekeler, I | 1 |
| Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Gori, AM; Marcucci, R; Migliorini, A; Moschi, G; Paniccia, R; Valenti, R; Vergara, R | 1 |
| Neumann, FJ; Trenk, D | 1 |
| Asif, A; Hentschel, DM | 1 |
| Rao, P; Wusirika, R | 1 |
| Fourtounas, C; Vlachojannis, JG | 1 |
| Armero, S; Arques, S; Barragan, P; Bonello, L; Bonello, R; Burignat-Bonello, C; Camoin-Jau, L; Collet, F; Com, O; Dignat-George, F; Giacomoni, MP; Paganelli, F; Rossi, P | 1 |
| Dörrler, K; Kastrati, A; Koch, W; Latz, W; Mehilli, J; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; von Beckerath, N | 1 |
| Milani, RV | 1 |
| Bonello, L; Kaneshige, K; Kent, KM; Lindsay, J; Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R; Xue, Z | 1 |
| Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Saracini, C; Sestini, I | 1 |
| Dean, J; Wanjun, C; Yingxin, Z; Yonghe, G; Yujie, Z; Yuyang, L; Zheng, C | 1 |
| Angiolillo, DJ; Berger, PB; Cannon, CP; Kandzari, DE; Price, MJ; Tanguay, JF; Teirstein, PS; Topol, EJ | 1 |
| Ajani, AE; Andrianopoulos, N; Black, A; Brennan, A; Butler, MJ; Clark, DJ; Dart, AM; Duffy, SJ; Eccleston, D; New, G; Reid, CM; Shaw, JA; Szto, G; Yan, BP | 1 |
| Fuller, M; Misra, S; Muldowney, JA; Pecot, CV | 1 |
| Gao, C; Li, D; Li, L; Ren, C | 1 |
| Esposito, RA | 1 |
| Cheng, WJ; Ge, HL; Guo, YH; Jia, DA; Liu, YY; Nie, B; Shi, DM; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhao, YX; Zhou, YJ | 1 |
| Bruskina, O; Byrne, RA; Ellert, J; Goedel, J; Kastrati, A; Massberg, S; Mehilli, J; Schömig, A; Schulz, S; Schuster, T; Ulm, K | 1 |
| Beauzile, P; Bonello, L; Gavini, R; Gurbel, P; Kaneshige, K; Kent, K; Pichard, AD; Pinto Slottow, TL; Satler, LF; Scheinowitz, M; Suddath, WO; Sushinsky, SJ; Tantry, U; Torguson, R; Waksman, R; Xue, Z | 1 |
| Bachoo, P; Brittenden, J; Ford, I; Nixon, GF; Wilson, AM | 1 |
| Bigalke, B; Gawaz, M; Geisler, T; Herdeg, C; Kilias, A; Kraibooj, H; May, AE; Rapin, M; Schwab, M; Simonenko, R; Stellos, K; Zürn, C | 1 |
| Bresson, D; Houdart, E; Mazighi, M; Saint Maurice, JP; Szatmary, Z | 1 |
| Collet, JP; Hulot, JS; Montalescot, G | 1 |
| Bahcivan, M; Erenler, BH; Gol, MK; Keceligil, HT; Kolbakir, F; Yucel, S | 1 |
| Popescu, WM | 1 |
| Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Jeong, JO; Jon, S; Kim, HS; Kim, JH; Kim, WJ; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, JY; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC | 1 |
| Aldama-López, G; Calviño-Santos, RA; Castro-Beiras, A; Flores-Ríos, X; Vázquez-González, N | 1 |
| Baumgartner, I; Becquemin, JP; Belch, JJ; Bergqvist, D; Biasi, BM; Biasi, GM; Cairols, M; Clement, D; Diehm, C; Dormandy, J; Eikelboom, B; Golledge, J; Hiatt, WR; Jawien, A; Leizorovicz, A; Lepäntalo, M; Matyas, L; Minar, E; Norgren, L; Stonebridge, P; Vermassen, F | 1 |
| Bouman, HJ; Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Ruven, HJ; Ten Berg, JM; van 't Hof, AW; van Werkum, JW; Zwart, B | 1 |
| Huber, K | 1 |
| Gao, G; Hu, S; Lu, B; Lu, J; Pi, Y; Zheng, Z | 1 |
| Anand, S; Connolly, S; Eikelboom, JW; Ellins, ML; Jung, H; Lamy, A; Sheth, T; Sun, JC; Teoh, KH; Whitlock, RP; Yusuf, S | 1 |
| Bouman, HJ; Breet, NJ; Hackeng, CM; Harmsze, AM; Kelder, JC; ten Berg, JM; van Werkum, JW | 1 |
| Bernlochner, I; Byrne, RA; Kastrati, A; Koch, W; Massberg, S; Mayer, K; Mehilli, J; Schömig, A; Schulz, S; Sibbing, D | 1 |
| Refiker, M | 1 |
| Conte, MS | 1 |
| Erlinge, D; James, S; Koul, S; Lagerqvist, B; Scherstén, F; Smith, JG | 1 |
| Gaglia, MA; Waksman, R | 1 |
| Biocina, B; Gasparovic, H; Petricevic, M | 1 |
| Bisdas, T; Haverich, A; Teebken, OE | 1 |
| Avlonitis, VS; Hayes, AM; Parry, A; Planas, S | 1 |
| Kirkby, NS; Mitchell, JA; Warner, TD | 1 |
| Calver, AL; Corbett, S; Curzen, N; Dent, H; Gray, H; Radhakrishnan, A; Sambu, N; Simpson, IA | 1 |
| Di Tommaso, L; Lillo, S; Monaco, M; Pinna, GB; Schiavone, V; Stassano, P | 1 |
| Babic, D; Homan, R; Islak, C; Kizilkilic, O; Kocer, N; Metaxas, GE | 1 |
| Kang, HJ; Kang, J; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Park, JJ; Park, KW; Park, YB; Yang, HM | 1 |
| Ahlehoff, O; Charlot, M; Gislason, GH; Hansen, ML; Hansen, PR; Køber, L; Lindhardsen, J; Madsen, JK; Nielsen, LH; Olsen, AM; Torp-Pedersen, C | 1 |
| Cho, KI; Jang, JS; Je, HG; Jeong, YH; Jin, HY; Kim, BH; Kim, DI; Kim, DK; Kim, DS; Kim, WJ; Lee, JY; Lee, SW; Park, YH; Seo, JS; Seol, SH; Yang, TH | 1 |
| Borghesi, M; Ferrari, R; Parrinello, G; Tebaldi, M; Valgimigli, M; Vranckx, P | 1 |
| Ajani, AE; Bui, AB; Cheneau, E; Dieble, R; Kent, KK; Leborgne, L; Lindsay, J; Pichard, AD; Pinnow, E; Satler, LF; Waksman, R | 1 |
| Dühmke, E; Kantlehner, R; Klauss, V; König, A; Krötz, F; Pöllinger, B; Rieber, J; Schiele, TM; Sohn, HY; Theisen, K; Zahler, S | 1 |
| Buettner, HJ; Hunziker, P; Marsch, S; Mueller, C; Neumann, FJ; Perruchoud, A; Roskamm, H | 1 |
| Dymond, DS; Robinson, NM; Strike, PC | 1 |
| Shechter, M | 1 |
| Mikhailidis, DP; Shenton, BK; Smout, JD; Stansby, G | 1 |
| Berger, PB | 1 |
| Angiolillo, DJ; Bernardo, E; Jiménez-Quevedo, P; Sabaté, M | 1 |
| Stiefelhagen, P | 1 |
| Dalen, JE; Gutterman, D; Schünemann, HJ; Stein, PD | 1 |
| Prins, TR; Span, MM; Tielliu, IF; van den Dungen, JJ; Verhoeven, EL; Zeebregts, CJ | 1 |
| Aranki, SF; Cannon, CP; Mehta, SR | 1 |
| Blatt, A; Finkelstein, A; Frimmerman, A; George, J; Herz, I; Keren, G; Krakover, R; Massachi, R; Michowitz, Y; Miller, H | 1 |
| Wolak, A; Zahger, D | 1 |
| Fayad, P; Frentzko, M; Hopkins, N; Katzen, BT; Kuntz, RE; Mishkel, G; Ouriel, K; Satler, L; Wechsler, L; Whitlow, P; Wholey, MH; Yadav, JS | 1 |
| Bocek, P | 1 |
| Beck, GJ; Dember, LM; Dixon, BS; Feldman, HI; Gassman, JJ; Greene, T; Himmelfarb, J; Hunsicker, LG; Kaufman, JS; Kusek, JW; Lawson, JH; Middleton, JP; Radeva, M; Schwab, SJ; Whiting, JF | 1 |
| Bui, A; Chu, WW; Clavijo, LC; Fournadjieva, J; Gevorkian, N; Kent, KM; Kim, SW; Kuchulakanti, PK; Ohlmann, P; Pichard, AD; Rha, SW; Satler, LF; Smith, K; Suddath, WO; Torguson, R; Waksman, R; Xue, Z | 1 |
| Cherian, KM; Jai Shankar, K; Jaiswal, P | 1 |
| Haaverstad, R; Halvorsen, D; Ibrahim, K; Karevold, A; Tjomsland, O; Wahba, A; Wiseth, R | 1 |
| Daemgen-von Brevern, G; Geisen, C; Klaeffling, C; Lindhoff-Last, E; Luxembourg, B; Mani, H; Strubel, G; Toennes, SW | 1 |
| Flaherty, CA; Lee, VH; Lopes, DK; Prabhakaran, S; Wells, KR | 1 |
| Smith, D; Srinivasan, M | 1 |
| Allon, M; Beck, GJ; Braden, GL; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Gassman, JJ; Greenberg, A; Greene, T; Himmelfarb, J; Ikizler, TA; Kaufman, JS; Kusek, JW; Meyers, CM; Radeva, MK; Rocco, MV; Vazquez, MA | 1 |
| Tonelli, M | 1 |
| Hanaoka, T | 1 |
| Eigler, NL; Forrester, JS; Frimerman, A; Herbert, JM; Kaul, S; Litvack, F; Makkar, RR; Nakamura, M; Shah, PK | 1 |
| Clagett, GP; Jackson, MR | 1 |
| Dillon, JC; Dillon, WC; Eckert, GJ; Ritchie, ME | 1 |
| Dieter, RS | 1 |
| Chew, DP; Moliterno, DJ; Mukherjee, D; Raymond, RE; Robbins, M; Yadav, JS | 1 |
| Marks, AR; Marx, SO | 1 |
| Gutersohn, A; Hetzer, R; Mülling, C; Musci, M; Sänger, S; Schaffner, T; Wellnhofer, E; Zurbrügg, HR | 1 |
| Acipayam, M; Canbaz, S; Duran, E; Ege, T | 1 |
| Amornsak, N; Chatlaong, B; Intayakorn, U; Laothavorn, P; Leelaprute, M; Nasawadi, C; Piamsomboon, C; Saguanwong, S; Tanprasert, P | 1 |
| Cazenave, JP; Freund, M; Mantz, F | 1 |
15 review(s) available for clopidogrel and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Meta-Analysis Comparing P2Y
Topics: Acute Coronary Syndrome; Aspirin; Cause of Death; Clopidogrel; Graft Occlusion, Vascular; Hemorrhage; Humans; Myocardial Infarction; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Ticagrelor | 2020 |
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Models, Statistical; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2013 |
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.
Topics: Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment | 2014 |
Wandering stent within the pulmonary circulation.
Topics: Aged, 80 and over; Angiography, Digital Subtraction; Anticoagulants; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis Implantation; Catheterization, Central Venous; Clopidogrel; Endovascular Procedures; Foreign-Body Migration; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Humans; Kidney Failure, Chronic; Male; Platelet Aggregation Inhibitors; Pulmonary Artery; Renal Dialysis; Stents; Ticlopidine; Treatment Outcome; Upper Extremity | 2014 |
Resistance to antiplatelet drugs: what progress has been made?
Topics: Aspirin; Clopidogrel; Graft Occlusion, Vascular; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Precision Medicine; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Treatment Failure | 2014 |
Use of antiplatelet drugs after cardiac operations.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Drug Therapy, Combination; Graft Occlusion, Vascular; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency | 2014 |
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.
Topics: Aged; Clopidogrel; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Risk Assessment; Stents; Thrombosis; Ticlopidine | 2015 |
Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty.
Topics: Aged; Angioplasty; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Graft Occlusion, Vascular; Humans; Lower Extremity; Male; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Spain; Ticlopidine; Treatment Outcome | 2016 |
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
Topics: Acute Coronary Syndrome; Analysis of Variance; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; Death, Sudden, Cardiac; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome | 2017 |
Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Cardiovascular Diseases; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Graft Occlusion, Vascular; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency | 2009 |
Systematic review of thienopyridine discontinuation and its impact upon clinical outcomes.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Administration Schedule; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
Topics: Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2012 |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Aspirin; Clopidogrel; Contraindications; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Assessment; Ticlopidine; Veins | 2004 |
Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery.
Topics: Administration, Oral; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Ticlopidine | 2005 |
Antithrombotic therapy in peripheral arterial occlusive disease.
Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, Carotid; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 1998 |
33 trial(s) available for clopidogrel and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study.
Topics: Aged; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Tomography, Optical Coherence; Treatment Outcome | 2018 |
Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial.
Topics: Aged; Angiography; Clopidogrel; Coronary Artery Bypass; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Lipoproteins, HDL; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Period; Risk Assessment; Saphenous Vein; Ticlopidine; Tunica Intima | 2013 |
Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
Topics: Aged; Clopidogrel; Coronary Artery Bypass; Double-Blind Method; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Male; Middle Aged; Prospective Studies; Saphenous Vein; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Effect of clopidogrel use post coronary artery bypass surgery on graft patency.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Education, Medical, Continuing; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Reference Values; Regression Analysis; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency | 2014 |
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.
Topics: Aspirin; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Sirolimus; Ticlopidine; Treatment Outcome | 2014 |
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Recurrence; Sex Factors; Stents; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome | 2014 |
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
Topics: Aged; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Predictive Value of Tests; Risk Assessment; Saphenous Vein; Ticlopidine; Vascular Patency | 2014 |
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Failure; Stroke; Ticlopidine; Treatment Outcome | 2015 |
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Femoral Artery; Graft Occlusion, Vascular; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Radial Artery; Stents; Ticlopidine; Treatment Outcome | 2016 |
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
Topics: Administration, Oral; Aged; Aspirin; Clopidogrel; Coronary Vessels; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima | 2016 |
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Cause of Death; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Graft Occlusion, Vascular; Hemorrhage; Humans; Mortality; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Time Factors | 2016 |
The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombocytosis; Ticlopidine; Treatment Outcome | 2008 |
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Drug Resistance, Multiple; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Radiography; Risk Factors; Ticlopidine | 2008 |
Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis.
Topics: Acute Disease; Aged; Angina Pectoris; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Monitoring, Physiologic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome | 2009 |
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2009 |
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.
Topics: Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Eluting Stents; Electrocardiography; Graft Occlusion, Vascular; Humans; Male; Myocardial Ischemia; Myocardial Revascularization; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2009 |
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Female; Graft Occlusion, Vascular; Graft Rejection; Graft Survival; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Probability; Prognosis; Survival Rate; Ticlopidine; Treatment Outcome; Vascular Patency | 2009 |
Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Aspirin; Biomarkers; Blotting, Western; Cell Proliferation; Cells, Cultured; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; E-Selectin; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Graft Occlusion, Vascular; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Mitogen-Activated Protein Kinase 3; Multivariate Analysis; Muscle, Smooth, Vascular; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Probability; Radiography; Reference Values; Statistics, Nonparametric; Ticlopidine | 2009 |
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2010 |
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.
Topics: Aged; Amputation, Surgical; Aspirin; Australia; Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Kaplan-Meier Estimate; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Placebo Effect; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Reoperation; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency; Veins | 2010 |
Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
Topics: Administration, Oral; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Saphenous Vein; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vascular Patency | 2010 |
Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Double-Blind Method; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Ischemia; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Preoperative Care; Prospective Studies; Ticlopidine; Treatment Outcome | 2010 |
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Ticlopidine; Treatment Outcome | 2011 |
Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.
Topics: Administration, Oral; Aged; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Logistic Models; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Popliteal Artery; Proportional Hazards Models; Prospective Studies; Ticlopidine; Treatment Outcome; Vascular Patency; Warfarin | 2012 |
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY).
Topics: Aged; Clopidogrel; Coronary Restenosis; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Graft Occlusion, Vascular; Humans; Hyperplasia; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Sirolimus; Stents; Stroke; Ticlopidine; Tunica Intima | 2013 |
Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS.
Topics: Aspirin; Brachytherapy; Clopidogrel; Coronary Restenosis; Drug Administration Schedule; Female; Gamma Rays; Graft Occlusion, Vascular; Heart Diseases; Humans; Iridium Radioisotopes; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk; Stents; Ticlopidine; Time; Treatment Outcome | 2002 |
Sustained platelet activation following intracoronary beta irradiation.
Topics: Angioplasty, Balloon, Coronary; Beta Particles; Blood Platelets; Brachytherapy; CD40 Ligand; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Prospective Studies; Stents; Strontium Radioisotopes; Ticlopidine; Yttrium Radioisotopes | 2002 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Survival Rate; Ticlopidine; Time Factors | 2003 |
Combination antiplatelet therapy in patients with peripheral vascular bypass grafts.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Female; Flow Cytometry; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine | 2004 |
Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis; Cerebrovascular Disorders; Clopidogrel; Cohort Studies; Comorbidity; Drug Resistance; Female; Graft Occlusion, Vascular; Humans; Illinois; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stents; Ticlopidine | 2008 |
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Clopidogrel; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombosis; Ticlopidine; Vascular Patency | 2008 |
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2001 |
87 other study(ies) available for clopidogrel and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Early asymptomatic graft failure in coronary artery bypass grafting: a study based on computed tomography angiography analysis.
Topics: Aspirin; Clopidogrel; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Bypass; Female; Graft Occlusion, Vascular; Humans; Retrospective Studies; Treatment Outcome; Vascular Patency | 2023 |
Long-Term Efficacy of Extended Dual Antiplatelet Therapy After Left Main Coronary Artery Bifurcation Stenting.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Registries; Republic of Korea; Retrospective Studies; Survival Rate; Time Factors | 2020 |
Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Cause of Death; Clopidogrel; Drug-Eluting Stents; Graft Occlusion, Vascular; Hemorrhage; Humans; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Recurrence; Thrombosis; Young Adult | 2020 |
Diffuse saphenous vein graft thrombosis: resolution after one month of apixaban and dual antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Graft Occlusion, Vascular; Humans; Male; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Saphenous Vein; Thrombosis; Treatment Outcome | 2020 |
Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model.
Topics: Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Factor Xa Inhibitors; Graft Occlusion, Vascular; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Swine; Tomography, Optical Coherence | 2022 |
Dual Antiplatelet Therapy Duration After Venous Sinus Stenting for Idiopathic Intracranial Hypertension and Stent Survival-Is Longer Necessarily Better? A Meta-Regression.
Topics: Adult; Aspirin; Central Venous Pressure; Clopidogrel; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Linear Models; Male; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Pseudotumor Cerebri; Recurrence; Regression Analysis; Retrospective Studies; Sinus Thrombosis, Intracranial; Spinal Puncture; Stents; Treatment Failure; Treatment Outcome | 2021 |
Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Topics: Adenosine; Aged; Blue Cross Blue Shield Insurance Plans; Clopidogrel; Drug Utilization Review; Ethnicity; Female; Graft Occlusion, Vascular; Hemorrhage; Hospital Mortality; Humans; Male; Michigan; Middle Aged; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Preoperative Period; Purinergic P2Y Receptor Antagonists; Stents; Ticagrelor; Ticlopidine; Time Factors | 2017 |
Preventing graft restenosis after coronary artery bypass grafting with tissue-type plasminogen activator.
Topics: Aged; Aspirin; Blood Coagulation; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Prospective Studies; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome | 2017 |
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).
Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Graft Occlusion, Vascular; Humans; Incidence; Israel; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Quebec; Registries; Risk Assessment; Risk Factors; Survival Rate; Ticlopidine; United States | 2017 |
High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACS.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Drug Administration Schedule; Female; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Netherlands; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stents; Ticlopidine | 2017 |
Impact of Double Loading Regimen of Clopidogrel on Final Angiographic Results, Incidence of Upper Gastrointestinal Bleeding and Clinical Outcomes in Patients with STEMI Undergoing Primary Coronary Intervention.
Topics: Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Survival Rate; Taiwan; Thrombolytic Therapy; Ticlopidine; Time Factors | 2017 |
Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Clopidogrel; Coronary Artery Bypass; Databases, Factual; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Registries; Retrospective Studies; Risk Factors; Saphenous Vein; Ticagrelor; Time Factors; Treatment Outcome; United Kingdom | 2018 |
Thromboembolic Events with Enterprise Versus Pipeline: Porcine In Vivo Experiment.
Topics: Angiography, Digital Subtraction; Animals; Brain Ischemia; Carotid Artery, Common; Clopidogrel; Disease Models, Animal; Embolization, Therapeutic; Feasibility Studies; Graft Occlusion, Vascular; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Failure; Stents; Sus scrofa; Swine; Thromboembolism | 2019 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult | 2019 |
Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).
Topics: Acute Coronary Syndrome; Aged; Aspirin; Case-Control Studies; Clopidogrel; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Testing; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12 | 2019 |
Dual platelet antiaggregation therapy after myocardial revascularization surgery.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome; Vascular Patency | 2019 |
Five years on dual-antiplatelet therapy. DES thrombosis after clopidogrel withdrawal.
Topics: Aged; Antineoplastic Agents, Phytogenic; Clopidogrel; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Time Factors; Ultrasonography, Interventional; Withholding Treatment | 2013 |
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Retrospective Studies; Severity of Illness Index; Sirolimus; Survival Analysis; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment | 2014 |
Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.
Topics: Aged; Alleles; Angiography, Digital Subtraction; Ankle Brachial Index; Arteriosclerosis Obliterans; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Endovascular Procedures; Female; Femoral Artery; Follow-Up Studies; Genotype; Graft Occlusion, Vascular; Humans; Leg; Male; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Prosthesis Failure; Stents; Ticlopidine; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex | 2014 |
An atypical presentation of an extremely late stent thrombosis after more than 7 years (2634 days) of DES implantation in a patient without obvious risk factors on regular dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine; Time Factors | 2014 |
Relationship between hyporesponsiveness to clopidogrel measured by thrombelastography and in stent restenosis in patients undergoing percutaneous coronary intervention.
Topics: Clopidogrel; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Factors; Thrombelastography; Ticlopidine | 2014 |
Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy.
Topics: Absorbable Implants; Adenosine; Adult; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Graft Occlusion, Vascular; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stents; Ticagrelor; Ticlopidine; Tirofiban; Tissue Scaffolds; Tyrosine | 2015 |
Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Artery Disease; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Precision Medicine; Prospective Studies; Registries; Stents; Thiophenes; Ticagrelor; Ticlopidine | 2014 |
Angiographic and clinical results of everolimus-eluting stent utilization in saphenous vein graft lesions (ARES).
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Drug-Eluting Stents; Everolimus; Female; Graft Occlusion, Vascular; Humans; Male; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Reoperation; Saphenous Vein; Ticlopidine | 2015 |
Effectiveness of prolonged clopidogrel-based dual antiplatelet therapy after drug-eluting stent implantation: Evidence-based meta-analysis.
Topics: Aged; Aspirin; Clopidogrel; Coronary Restenosis; Drug Administration Schedule; Drug Combinations; Drug-Eluting Stents; Evidence-Based Medicine; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Survival Rate; Ticlopidine; Treatment Outcome | 2015 |
Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus.
Topics: Aged; Blood Platelets; Chronic Disease; Clopidogrel; Coronary Occlusion; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Italy; Male; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prognosis; Retrospective Studies; Survival Rate; Ticlopidine; Time Factors | 2015 |
High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention.
Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Time Factors | 2016 |
Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Diabetes Mellitus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hemorrhage; Humans; Incidence; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Poland; Prospective Studies; Thrombosis; Ticlopidine | 2016 |
Aspirin resistance an underestimated risk in patients with drug-eluting stents?
Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Drug Resistance; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2008 |
Effect of clopidogrel on arteriovenous fistulas for dialysis.
Topics: Arteriovenous Shunt, Surgical; Clopidogrel; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Renal Dialysis; Ticlopidine | 2008 |
Effect of clopidogrel on arteriovenous fistulas for dialysis.
Topics: Arteriovenous Shunt, Surgical; Clopidogrel; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombosis; Ticlopidine | 2008 |
Effect of clopidogrel on arteriovenous fistulas for dialysis.
Topics: Arteriovenous Shunt, Surgical; Clopidogrel; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombosis; Ticlopidine | 2008 |
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Genotype; Graft Occlusion, Vascular; Homozygote; Humans; Male; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Stents; Ticlopidine | 2009 |
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine | 2009 |
Prolonged dual antiplatelet therapy improves clinical outcomes in high-risk patients implanted with sirolimus-eluting stents.
Topics: Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Sirolimus; Ticlopidine; Treatment Outcome | 2009 |
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
Topics: Aged; Clopidogrel; Coronary Stenosis; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome; Victoria | 2009 |
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Thrombosis; Ticlopidine; Time Factors | 2009 |
Invited commentary.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Female; Graft Occlusion, Vascular; Graft Survival; Humans; Male; Platelet Aggregation Inhibitors; Sensitivity and Specificity; Ticlopidine; Vascular Patency | 2009 |
Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis; Body Mass Index; Clopidogrel; Coronary Disease; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombosis; Ticlopidine | 2009 |
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.
Topics: Aged; Blood Vessel Prosthesis; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2009 |
Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Ticlopidine | 2009 |
Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome; Young Adult | 2010 |
Platelet aggregation in intracranial stents may mimic in-stent restenosis.
Topics: Cerebral Angiography; Clopidogrel; Diagnosis, Differential; Drug Resistance; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Failure | 2010 |
Stent thrombosis: who's guilty?
Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Blood Vessel Prosthesis; Cardiology; Clinical Competence; Clopidogrel; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Thiophenes; Ticlopidine | 2009 |
Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass.
Topics: Administration, Oral; Animals; Atorvastatin; Benzopyrans; Calcium Dobesilate; Cardiovascular Agents; Carotid Stenosis; Clopidogrel; Disease Models, Animal; Ethanolamines; Graft Occlusion, Vascular; Heptanoic Acids; Hyperplasia; Jugular Veins; Male; Nebivolol; Pyrroles; Rabbits; Ticlopidine; Tunica Intima; Vascular Surgical Procedures | 2009 |
Perioperative management of the patient with a coronary stent.
Topics: Algorithms; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Time Factors | 2010 |
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.
Topics: Blood Vessel Prosthesis; Clopidogrel; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2010 |
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Vessel Prosthesis; Case-Control Studies; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Therapy, Combination; Female; Genotype; Graft Occlusion, Vascular; Heterozygote; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2010 |
Genetic variability in response to clopidogrel therapy: clinical implications.
Topics: Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine | 2010 |
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Gene Frequency; Genotype; Graft Occlusion, Vascular; Heterozygote; Homozygote; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Stents; Ticlopidine | 2011 |
Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting surgery.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Care; Preoperative Care; Randomized Controlled Trials as Topic; Ticlopidine | 2011 |
Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial".
Topics: Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Peripheral Arterial Disease; Placebo Effect; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome; Veins | 2011 |
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Propensity Score; Shock, Cardiogenic; Stents; Ticlopidine; Treatment Outcome | 2011 |
Letter by Gasparovic et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
Topics: Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Artery Disease; Drug Resistance; Follow-Up Studies; Graft Occlusion, Vascular; Hemorheology; Humans; Hyperplasia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Saphenous Vein; Ticlopidine; Tunica Intima | 2011 |
Letter by Bisdas et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
Topics: Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Artery Disease; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Resistance; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Saphenous Vein; Ticlopidine; Tunica Intima | 2011 |
Occlusion of modified Blalock-Taussig shunt after clopidogrel cessation.
Topics: Anticoagulants; Aspirin; Blalock-Taussig Procedure; Clopidogrel; Fatal Outcome; Graft Occlusion, Vascular; Heart Arrest; Heart Septal Defects, Ventricular; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Male; Pulmonary Atresia; Reoperation; Status Epilepticus; Substance Withdrawal Syndrome; Ticlopidine; Tricuspid Atresia | 2012 |
Short thromboelastography and the identification of high platelet reactivity while on and off therapy.
Topics: Clopidogrel; Coronary Thrombosis; Drug Resistance; Female; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Registries; Ticlopidine | 2012 |
Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Resistance; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Registries; Thrombelastography; Ticlopidine; Treatment Outcome; United Kingdom | 2012 |
Utility of VasoCT in the treatment of intracranial aneurysm with flow-diverter stents.
Topics: Adult; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Catheterization; Cerebral Angiography; Cerebral Arteries; Clopidogrel; Female; Fluoroscopy; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Tomography, X-Ray Computed | 2012 |
Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention.
Topics: Aged; Amlodipine; Angioplasty, Balloon, Coronary; Clopidogrel; Cytochrome P-450 CYP3A; Drug Interactions; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prospective Studies; Stroke; Ticlopidine | 2012 |
Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study.
Topics: Adult; Aged; Clopidogrel; Denmark; Drug Administration Schedule; Epidemiologic Methods; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Failure; Recurrence; Stents; Thrombosis; Ticlopidine; Withholding Treatment | 2012 |
The use of the X-Sizer transluminal extraction catheter as an adjunct to stenting of occluded saphenous vein grafts.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Aspirin; Blood Vessel Prosthesis Implantation; Catheters, Indwelling; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Female; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Saphenous Vein; Stents; Ticlopidine | 2003 |
Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
Topics: Atorvastatin; Clopidogrel; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2003 |
Resistance to antiplatelet drugs: is it real or relevant?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2004 |
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?
Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2004 |
[Cardiovascular pharmacology].
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Fatty Acids, Omega-3; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2004 |
Endovascular treatment of popliteal artery aneurysms: results of a prospective cohort study.
Topics: Aged; Aged, 80 and over; Aneurysm; Angioplasty; Blood Vessel Prosthesis Implantation; Clopidogrel; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Popliteal Artery; Prospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2005 |
Stent thrombosis in patients treated with thienopyridines: clinical description of 10 cases.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Radiography; Retrospective Studies; Risk Factors; Severity of Illness Index; Stents; Ticlopidine | 2004 |
Management and prevention of thrombotic stent occlusion.
Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Clopidogrel; Emergency Treatment; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2005 |
Feasibility trial of carotid stenting with and without an embolus protection device.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Artery, Common; Carotid Stenosis; Clopidogrel; Feasibility Studies; Female; Graft Occlusion, Vascular; Humans; Intracranial Embolism; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Radiography; Stents; Stroke; Survival Rate; Ticlopidine; Treatment Outcome | 2005 |
Idiopathic spontaneous coronary artery dissection and drug-eluting stents.
Topics: Adult; Aortic Dissection; Aspirin; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Female; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2006 |
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Clopidogrel; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Ticlopidine; Treatment Outcome | 2005 |
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
Topics: Aged; Angiography; Case-Control Studies; Clopidogrel; Drug Delivery Systems; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Renal Insufficiency; Sirolimus; Stents; Thrombosis; Ticlopidine; Treatment Outcome | 2006 |
Images in cardiology. Unexpected response of saphenous vein graft occlusion to antiplatelet drugs.
Topics: Aged; Aspirin; Clopidogrel; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation Inhibitors; Saphenous Vein; Ticlopidine | 2006 |
Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery.
Topics: Clopidogrel; Cohort Studies; Coronary Artery Bypass, Off-Pump; Female; Graft Occlusion, Vascular; Graft Survival; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome; Vascular Patency | 2006 |
Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Factitious Disorders; Female; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Hirudins; Humans; Iliac Artery; Middle Aged; Munchausen Syndrome; Phenprocoumon; Platelet Aggregation Inhibitors; Recombinant Proteins; Recurrence; Reoperation; Ticlopidine; Treatment Refusal; Vascular Surgical Procedures | 2007 |
Drug interaction with anti-mycobacterial treatment as a cause of clopidogrel resistance.
Topics: Abciximab; Aged; Antibiotics, Antitubercular; Antibodies, Monoclonal; Clopidogrel; Drug Interactions; Drug Resistance; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Mycobacterium avium-intracellulare Infection; Myocardial Infarction; Opportunistic Infections; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine | 2008 |
Randomized trials in hemodialysis patients: time to step up to the plate.
Topics: Arteriovenous Shunt, Surgical; Clopidogrel; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Dialysis; Ticlopidine | 2008 |
[An experimental study of arterial graft implantation--the effects of an anti-thrombin agent, argatroban, and an anti-platelet agent, clopidogrel (SR 25990 C) on the inner capsule].
Topics: Angioscopy; Animals; Antithrombins; Aorta, Abdominal; Arginine; Blood Coagulation; Blood Vessel Prosthesis; Clopidogrel; Dogs; Fibrinolysis; Graft Occlusion, Vascular; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Ticlopidine | 1994 |
Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Blood Platelets; Clopidogrel; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Occlusion, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Swine; Ticlopidine | 1998 |
Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Cardiac Catheterization; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stents; Thrombocytopenia; Thrombolytic Therapy; Ticlopidine | 2000 |
Risk of neutropenia with clopidogrel.
Topics: Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Disease; Graft Occlusion, Vascular; Humans; Neutropenia; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2000 |
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Carotid Stenosis; Clopidogrel; Comorbidity; Coronary Artery Bypass; Drug Therapy, Combination; Female; Fibrinogen; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Microspheres; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk; Stents; Ticlopidine | 2001 |
Bench to bedside: the development of rapamycin and its application to stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Calcineurin Inhibitors; Carrier Proteins; Cell Cycle Proteins; Cell Division; Cell Movement; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Graft Occlusion, Vascular; Humans; Hyperplasia; Macromolecular Substances; Phosphotransferases (Alcohol Group Acceptor); Platelet Aggregation Inhibitors; Signal Transduction; Sirolimus; Stents; Tacrolimus; Tacrolimus Binding Protein 1A; Ticlopidine; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins; Tunica Media; Vascular Patency | 2001 |
Prevention of venous graft sclerosis with clopidogrel and aspirin combined with a mesh tubing in a dog model of arteriovenous bypass grafting.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Artery, Common; Clopidogrel; Dogs; Drug Therapy, Combination; Graft Occlusion, Vascular; Jugular Veins; Platelet Aggregation Inhibitors; Ticlopidine | 2001 |
Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting.
Topics: Arteries; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Graft Occlusion, Vascular; Humans; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Patency | 2001 |
[Arterioarterial shunt coated with collagen. A model of acute arterial thrombosis for testing antithrombotic agents in rats].
Topics: Animals; Aspirin; Carotid Arteries; Clopidogrel; Collagen; Disease Models, Animal; Fistula; Graft Occlusion, Vascular; Male; Models, Biological; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thrombolytic Therapy; Thrombosis; Ticlopidine | 1991 |